Number of megarounds drops 38% in first half as biotechs struggle against worsening slumpnews2025-07-03T12:28:26+00:00July 3rd, 2025|Endpoints News|
AN Venture Partners lines up $200M freshman fund to champion Japanese innovationnews2025-07-01T20:00:25+00:00July 1st, 2025|Endpoints News|
Unnatural Products taps argenx’s help for ringed molecules, expands internal work into obesitynews2025-07-01T12:00:39+00:00July 1st, 2025|Endpoints News|
Exclusive: Bob Langer-founded Syntis Bio gets $33M Series A for obesity, rare disease drugsnews2025-07-01T10:00:46+00:00July 1st, 2025|Endpoints News|
Khosla Ventures backs ‘therapeutic plasma exchange’ startup Circulate Healthnews2025-06-30T17:00:26+00:00June 30th, 2025|Endpoints News|
Apple Tree Partners’ biotechs ‘face imminent collapse’ as firm battles Russian investor in courtnews2025-06-30T15:16:42+00:00June 30th, 2025|Endpoints News|
OpenAI-backed biotech debuts antibody-making AI modelsnews2025-06-30T10:00:03+00:00June 30th, 2025|Endpoints News|
Why Commure, one of healthcare’s most deal-hungry startups, plans to buy more scribesnews2025-06-26T13:00:29+00:00June 26th, 2025|Endpoints News|
Former Pfizer CSO Mikael Dolsten joins board of gene editing startupnews2025-06-24T17:37:40+00:00June 24th, 2025|Endpoints News|
Novo Nordisk ends partnership with Hims over compounded drugsnews2025-06-23T15:23:23+00:00June 23rd, 2025|Endpoints News|
